vimarsana.com

Page 31 - முதலீடு செய்தி வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Do You Need Gold for Retirement? | Learn the Pros and Cons

With that in mind, it’s interesting to take a balanced look at gold investing for your retirement plan after all, though gold is certainly a compelling investment, it’s not right for everyone. The lists of pros and cons below are designed to help you figure out if gold for retirement will work for you. Gold for retirement: The pros If you’ve already invested in gold, you’re likely well aware of the benefits that can come when you buy gold. However, you may be wondering if those financial benefits will carry over if you invest in gold for your retirement savings. Here’s a brief overview of the positive side of saving gold for retirement:

Graphite in the Electric Vehicle Automobile Industry

In order to meet its 2025 EV sales targets, Volkswagen needs 300 GWh of lithium-ion battery production,Tesla needs 350 GWh, Daimler needs 200 GWh and China needs at least 250 GWh. In order to meet its 2025 EV sales targets, Volkswagen needs 300 gigawatt (GWh)hours of lithium-ion battery production, Tesla needs 350 GWh, Daimler needs 200 GWh and China needs at least 250 GWh. On top of that are all the other automobile manufacturers plus the grid storage market. For automobile manufacturers to execute their business plans, these figures translate into a requirement to invest billions of dollars in multiple new graphite mines and upgrading facilities. Graphite requires the largest production increase of all the battery minerals, and almost all of it currently comes from China.

BriaCell Announces Investor and Media Outreach Programs

BriaCell Announces Investor and Media Outreach Programs BriaCell Therapeutics Corp. a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that it has recently expanded its investor and media outreach platform in order to enhance communication with investors and increase investor awareness of and interest in the Company, its product candidates, and its clinical programs. The comprehensive program is expected … BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that it has recently expanded its investor and media outreach platform in order to enhance communication with investors and increase investor awareness of and interest in the Company, its product candidates, and its clinical programs. The comprehensive program is expected to enhance BriaCell’s di

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.